Molecular epidemiology of carbapenem-resistant Acinetobacter spp. from XiangYa Hospital, in Hunan Province, China

Journal of Basic Microbiology

Volumn 53, Issue 2, 2013, Pages 121-127

  Chen, Zhenhua ^a   Liu, Wenen ^a   Zhang, Yunli ^a   Li, Yanbing ^a   Jian, Zijuan ^a   Deng, Hongli ^a   Zou, Mingxiang ^a   Liu, Yuanyuan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Acinetobacter spp.; BlaOXA 23; Carbapenem resistant

Indexed keywords

BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEMASE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ARTICLE; CHINA; CLASSIFICATION; CROSS INFECTION; DRUG EFFECT; EPIDEMIC; GENOTYPE; HOSPITAL; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; MULTIDRUG RESISTANCE; POLYMERASE CHAIN REACTION; SECRETION (PROCESS);

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; BACTERIAL PROTEINS; BETA-LACTAMASES; CHINA; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENOTYPE; HOSPITALS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; POLYMERASE CHAIN REACTION;

EID: 84873574746     PISSN: 0233111X     EISSN: 15214028     Source Type: Journal    
DOI: 10.1002/jobm.201100420     Document Type: Article

References (38)

1. Afzal-Shah, M., Woodford, N., Livermore, D.M., 2001. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother., 45, 583-588.
2. Bogaerts, P., Naas, T., Wybo, I., Bauraing, C., et al., 2006. Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium. J. Clin. Microbiol., 44, 4189-4192.
3. Boo, T.W., Crowley, B., 2009. Detection of blaOXA-58 and blaOXA-23-like genes in carbapenem-susceptible Acinetobacter clinical isolates: should we be concerned? J. Med. Microbiol., 58, 839-841.
4. Bou, G., Cervero, G., Dominguez, M.A., Quereda, C., Martinez-Beltran, J., 2000. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases. J. Clin. Microbiol., 38, 3299-3305.
5. Corbella, X., Montero, A., Pujol, M., Dominguez, M.A., et al., 2000. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J. Clin. Microbiol., 38, 4086-4095.
6. Da Silva, G.J., Correia, M., Vital, C., Ribeiro, G., et al., 2002. Molecular characterization of bla(IMP-5), a new integron-borne metallo-beta-lactamase gene from an Acinetobacter baumannii nosocomial isolate in Portugal. FEMS Microbiol. Lett., 215, 33-39.
7. Fournier, P.E., Vallenet, D., Barbe, V., Audic, S., et al., 2006. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet., 2: e7.
8. Goel, N., Chaudhary, U., Aggarwal, R., Bala, K., 2009. Antibiotic sensitivity pattern of gram negative bacilli isolated from the lower respiratory tract of ventilated patients in the Intensive care unit. Indian J. Crit. Care Med., 13, 148-151.
9. Grosso, F., Quinteira, S., Peixe, L., 2010. Emergence of an extreme-drug-resistant (XDR) Acinetobacter baumannii carrying blaOXA-23 in a patient with acute necrohaemorrhagic pancreatitis. J. Hosp. Infect., 75, 82-83.
10. Huys, G., Cnockaert, M., Vaneechoutte, M., Woodford, N., et al., 2005. Distribution of tetracycline resistance genes in genotypically related and unrelated multiresistant Acinetobacter baumannii strains from different European hospitals. Res. Microbiol., 156, 348-355.
11. Jeong, S.H., Bae, I.K., Park, K.O., An, Y.J., 2006. Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea. J. Microbiol., 44, 423-431.
12. Joyanes, P., del Carmen Conejo M., Martinez-Martinez, L., Perea, E.J., 2001. Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples. J. Clin. Microbiol., 39, 3247-3253.
13. Koh, T.H., Sng, L.H., Wang, G.C., Hsu, L.Y., Zhao, Y., 2007. IMP-4 and OXA beta-lactamases in Acinetobacter baumannii from Singapore. J. Antimicrob. Chemother., 59, 627-632.
14. Kuo, L.C., Teng, L.J., Yu, C.J., Ho, S.W., Hsueh, P.R., 2004. Dissemination of a clone of unusual phenotype of pandrug-resistant Acinetobacter baumannii at a university hospital in Taiwan. J. Clin. Microbiol., 42, 1759-1763.
15. Lee, K., Lim, Y.S., Yong, D., Yum, J.H., Chong, Y., 2003. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol., 41, 4623-4629.
16. Lee, Y., Yum, J.H., Kim, C.K., Yong, D., et al., 2010. Role of OXA-23 and AdeABC efflux pump for acquiring carbapenem resistance in an Acinetobacter baumannii strain carrying the blaOXA-66 gene. Ann. Clin. Lab. Sci., 40, 43-48.
17. Ling, T.K., Tam, P.C., Liu, Z.K., Cheng, A.F., 2001. Evaluation of VITEK 2 rapid identification and susceptibility testing system against gram-negative clinical isolates. J. Clin. Microbiol., 39, 2964-2966.
18. Loli, A., L. Tzouvelekis, S., Gianneli, D., Tzelepi, E., Miriagou, V., 2008. Outbreak of Acinetobacter baumannii with chromosomally encoded VIM-1 undetectable by imipenem-EDTA synergy tests. Antimicrob. Agents Chemother., 52, 1894-1896.
19. Mak, J.K., Kim, M.J., Pham, J., Tapsall, J., White, P.A., 2009. Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii. J. Antimicrob. Chemother., 63, 47-54.
20. Martins, A.F., Kuchenbecker, R., Sukiennik, T., Boff, R., et al., 2009. Carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme: dissemination in Southern Brazil. Infection, 37, 474-476.
21. Mendes, R.E., Spanu, T., Deshpande, L., Castanheira, M., et al., 2009. Clonal dissemination of two clusters of Acinetobacter baumannii producing OXA-23 or OXA-58 in Rome, Italy. Clin. Microbiol. Infect., 15, 588-592.
22. Pachon-Ibanez, M.E., Docobo-Perez, F., Lopez-Rojas, R., Dominguez-Herrera, J., et al., 2010. Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother., 54, 1165-1172.
23. Poirel, L., Marque, S., Heritier, C., Segonds, C., et al., 2005. OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob. Agents Chemother., 49, 202-208.
24. Principe, L., D'Arezzo, S., Capone, A., Petrosillo, N., Visca, P., 2009. In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii. Ann. Clin. Microbiol. Antimicrob., 8, 18.
25. Quale, J., Bratu, S., Landman, D., Heddurshetti, R., 2003. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin. Infect. Dis., 37, 214-220.
26. Ruiz, M., Marti, S., Fernandez-Cuenca, F., Pascual, A., Vila, J., 2007. High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain. Clin. Microbiol. Infect., 13, 1192-1198.
27. Senda, K., Arakawa, Y., Ichiyama, S., Nakashima, K., et al., 1996. PCR detection of metallo-beta-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum beta-lactams. J. Clin. Microbiol., 34, 2909-2913.
28. Sung, J.Y., Kwon, K.C., Park, J.W., Kim, Y.S., et al., 2008. Dissemination of IMP-1 and OXA type beta-lactamase in carbapenem-resistant Acinetobacter baumannii. Korean J. Lab. Med., 28, 16-23.
29. Thapa, B., Tribuddharat, C., Srifuengfung, S., Dhiraputra, C., 2010. High prevalence of bla(OXA)-23 in oligoclonal carbapenem-resistant Acinetobacter baumannii from Siriraj Hospital, Mahidol University, Bangkok, Thailand. Southeast Asian J. Trop. Med. Public Health, 41, 625-635.
30. Turton, J.F., Woodford, N., Glover, J., Yarde, S., et al., 2006. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J. Clin. Microbiol., 44, 2974-2976.
31. Uma Karthika R., Srinivasa Rao, R., Sahoo, S., Shashikala, P., et al., 2009. Phenotypic and genotypic assays for detecting the prevalence of metallo-beta-lactamases in clinical isolates of Acinetobacter baumannii from a South Indian tertiary care hospital. J. Med. Microbiol., 58, 430-435.
32. Vila, J., Marti, S., Sanchez-Cespedes, J., 2007. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J. Antimicrob. Chemother., 59, 1210-1215.
33. Wang, H., Guo, P., Sun, H., Yang, Q., et al., 2007. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob. Agents Chemother., 51, 4022-4028.
34. Yan, J.J., Hsueh, P.R., Ko, W.C., Luh, K.T., et al., 2001. Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob. Agents Chemother., 45, 2224-2228.
35. Yang, S.C., Chang, W.J., Chang, Y.H., Tsai, Y.S., et al., 2010. Prevalence of antibiotics resistance and OXA carbapenemases genes in multidrug-resistant Acinetobacter baumannii isolates in central Taiwan. Eur. J. Clin. Microbiol. Infect. Dis., 29, 601-604.
36. Yong, D., Lee, K., Yum, J.H., Shin, H.B., et al., 2002. Imipenem-EDTA disk method for differentiation of metallo-beta-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol., 40, 3798-3801.
37. Zhou, H., Pi, B.R., Yang, Q., Yu, Y.S., et al., 2007. Dissemination of imipenem-resistant Acinetobacter baumannii strains carrying the ISAba1 blaOXA-23 genes in a Chinese hospital. J. Med. Microbiol., 56, 1076-1080.
38. Zong, Z., Lu, X., Valenzuela, J.K., Partridge, S.R., Iredell, J., 2008. An outbreak of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemase in western China. Int. J. Antimicrob. Agents, 31, 50-54.